Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis

被引:87
|
作者
Asrani, Sumeet K. [1 ]
Trotter, James [1 ]
Lake, Jack [2 ]
Ahmed, Aijaz [3 ]
Bonagura, Anthony [4 ]
Cameron, Andrew [5 ]
DiMartini, Andrea [6 ]
Gonzalez, Stevan [7 ]
Im, Gene [8 ]
Martin, Paul [9 ]
Mathurin, Philippe [10 ]
Mellinger, Jessica [11 ]
Rice, John P. [12 ]
Shah, Vijay H. [13 ]
Terrault, Norah [14 ]
Wall, Anji [1 ]
Winder, Scott [11 ]
Klintmalm, Goran [1 ]
机构
[1] Baylor Univ, Med Ctr, 3410 Worth St,Suite 860, Dallas, TX 75246 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Optum, Philadelphia, PA USA
[5] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] Baylor All St Med Ctr, Ft Worth, TX USA
[8] Mt Sinai Hosp, New York, NY 10029 USA
[9] Univ Miami Hlth Syst, Miami, FL USA
[10] Hop Claude Huriez, Serv Hepatogastroenterol, Lille, France
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Univ Wisconsin, Madison, WI USA
[13] Mayo Clin, Rochester, MN USA
[14] Univ Southern Calif, Los Angeles, CA 90007 USA
关键词
DISEASE; EPIDEMIOLOGY; ALLOCATION; MORTALITY; SURVIVAL; OUTCOMES; TARGETS; GRAFTS; TRIALS; MODEL;
D O I
10.1002/lt.25681
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplantation (LT) for alcohol associated hepatitis (AH) remains controversial. We convened a consensus conference to examine various aspects of LT for AH. The goal was not to unequivocally endorse LT for AH; instead, it was to propose recommendations for programs that perform or plan to perform LT for AH. Criteria were established to determine candidacy for LT in the setting of AH and included the following: (1) AH patients presenting for the first time with decompensated liver disease that are nonresponders to medical therapy without severe medical or psychiatric comorbidities; (2) a fixed period of abstinence prior to transplantation is not required; and (3) assessment with a multidisciplinary psychosocial team, including a social worker and an addiction specialist/mental health professional with addiction and transplantation expertise. Supporting factors included lack of repeated unsuccessful attempts at addiction rehabilitation, lack of other substance use/dependency, acceptance of diagnosis/insight with a commitment of the patient/family to sobriety, and formalized agreement to adhere to total alcohol abstinence and counseling. LT should be avoided in AH patients who are likely to spontaneously recover. Short-term and longterm survival comparable to other indications for LT must be achieved. There should not be further disparity in LT either by indication, geography, or other sociodemographic factors. Treatment of alcohol-use disorders should be incorporated into pre- and post-LT care. The restrictive and focused evaluation process described in the initial LT experience for AH worldwide may not endure as this indication gains wider acceptance at more LT programs. Transparency in the selection process is crucial and requires the collection of objective data to assess outcomes and minimize center variation in listing. Oversight of program adherence is important to harmonize listing practices and outcomes.
引用
收藏
页码:127 / 140
页数:14
相关论文
共 50 条
  • [41] Liver Transplantation in Alcohol-Associated Liver Disease: Current Status and Future Landscape
    Louvet, Alexandre
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 809 - 817
  • [42] The landscape of liver transplantation for patients with alcohol-associated liver disease in the United States
    Vock, David M.
    Humphreville, Vanessa
    Ramanathan, Karthik V.
    Adams, Andrew B.
    Lim, Nicholas
    Nguyen, Vinh H.
    Wothe, Jillian K.
    Chinnakotla, Srinath
    LIVER TRANSPLANTATION, 2025, 31 (01) : 32 - 44
  • [43] Hepatocellular carcinoma: Consensus, controversies and future directions: A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting
    Burak, Kelly Warren
    Sherman, Morris
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (04) : 178 - 184
  • [44] Pregnancy and liver-related outcomes after alcohol-associated hepatitis: A global multicenter study
    Cooper, Katherine M.
    Patel, Ami K.
    Kaluri, Sonali
    Devuni, Deepika
    HEPATOLOGY COMMUNICATIONS, 2025, 9 (03)
  • [45] The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications
    Ayyala-Somayajula, Divya
    Dodge, Jennifer L.
    Zhou, Kali
    Terrault, Norah A.
    Yuan, Liyun
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (07)
  • [46] Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation
    Giard, Jeanne-Marie
    Dodge, Jennifer L.
    Terrault, Norah A.
    LIVER TRANSPLANTATION, 2019, 25 (09) : 1310 - 1320
  • [47] Liver transplantation in alcohol-associated liver disease: ensuring equity through new processes
    Messinger, John C. C.
    Hanto, Douglas W. W.
    Curry, Michael P. P.
    Ladin, Keren
    LIVER TRANSPLANTATION, 2023, 29 (05) : 539 - 547
  • [48] Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States
    Cotter, Thomas G.
    Mitchell, Mack C.
    Patel, Mausam J.
    Anouti, Ahmad
    Lieber, Sarah R.
    Rich, Nicole E.
    Arab, Juan Pablo
    Diaz, Luis Antonio
    Louissaint, Jeremy
    Kerr, Thomas
    Mufti, Arjmand R.
    Hanish, Steven I.
    Vagefi, Parsia A.
    Patel, Madhukar S.
    Vanwagner, Lisa B.
    Lee, William M.
    OLeary, Jacqueline G.
    Singal, Amit G.
    TRANSPLANTATION, 2024, 108 (01) : 225 - 234
  • [49] Orthotopic liver transplantation for patients with end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis
    Caputo, Fabio
    Testino, Gianni
    MINERVA SURGERY, 2021, 76 (05): : 444 - 449
  • [50] Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation
    Germani, Giacomo
    D'Arcangelo, Francesca
    Grasso, Marco
    Burra, Patrizia
    LIFE-BASEL, 2023, 13 (09):